Jane S. Han
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jane S. Han has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Kristie Qwan-Ting Liu
Affiliation Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America
2 shared publications - Frank Attenello
Department of Neurological Surgery, University of Southern California, Los Angeles, CA, USA
1 shared publication Frank J. Attenello
Affiliations Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America, Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America
1 shared publicationJosh Neman
Affiliation Department of Neurological Surgery, Physiology and Neuroscience, USC Brain Tumor Center, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America
1 shared publication- Justin Y. Cheng
University of Minnesota 4 Department of Chemical Engineering and Materials Science Minneapolis, Minnesota 55455
1 shared publication - Kathleen Tsung
Affiliation Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America
1 shared publication
Latest Publications
- Open Access
- 10 June 2024
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 20 (6) , e1011314
CRISPRi screen of long non-coding RNAs identifies LINC03045 regulating glioblastoma invasion
Introduction: Glioblastoma (GBM) invasion studies have focused on coding genes, while few studies evaluate long non-coding RNAs (lncRNAs), transcripts without protein-coding potential, for role in GBM invasion. We leveraged CRISPR-interference (CRISPRi) to evaluate invasive function of GBM-associated lncRNAs in an unbiased functional screen, characterizing and exploring the mechanism of identified candidates. Methods: We implemented a CRISPRi lncRNA loss-of-function screen evaluating association of lncRNA knockdown (KD) with invasion capacity in Matrigel. Top screen candidates were validated using CRISPRi and oligonucleotide(ASO)-mediated knockdown in three tumor lines. Clinical relevance of candidates was assessed via The Cancer Genome Atlas(TCGA) and Genotype-Tissue Expression(GTEx) survival analysis. Mediators of lncRNA effect were identified via differential expression analysis following lncRNA KD and assessed for tumor invasion using knockdown and rescue experiments. Results: Forty-eight lncRNAs were significantly associated with 33–83% decrease in invasion (pLINC03045, identified from effect size and p-value, demonstrated 82.7% decrease in tumor cell invasion upon knockdown, while LINC03045 expression was significantly associated with patient survival and tumor grade(pLINC03045 knockdown revealed that WASF3, previously implicated in tumor invasion studies, was highly correlated with lncRNA expression, while WASF3 KD was associated with significant decrease in invasion. Finally, WASF3 overexpression demonstrated rescue of invasive function lost with LINC03045 KD. Conclusion: CRISPRi screening identified LINC03045, a previously unannotated lncRNA, as critical to GBM invasion. Gene expression is significantly associated with tumor grade and survival. RNA-seq and mechanistic studies suggest that this novel lncRNA may regulate invasion via WASF3.
- 10 June 2024
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 20 (6) , e1011314
Open AccessCRISPRi screen of long non-coding RNAs identifies LINC03045 regulating glioblastoma invasion
Introduction: Glioblastoma (GBM) invasion studies have focused on coding genes, while few studies evaluate long non-coding RNAs (lncRNAs), transcripts without protein-coding potential, for role in GBM invasion. We leveraged CRISPR-interference (CRISPRi) to evaluate invasive function of GBM-associated lncRNAs in an unbiased functional screen, characterizing and exploring the mechanism of identified candidates. Methods: We implemented a CRISPRi lncRNA loss-of-function screen evaluating association of lncRNA knockdown (KD) with invasion capacity in Matrigel. Top screen candidates were validated using CRISPRi and oligonucleotide(ASO)-mediated knockdown in three tumor lines. Clinical relevance of candidates was assessed via The Cancer Genome Atlas(TCGA) and Genotype-Tissue Expression(GTEx) survival analysis. Mediators of lncRNA effect were identified via differential expression analysis following lncRNA KD and assessed for tumor invasion using knockdown and rescue experiments. Results: Forty-eight lncRNAs were significantly associated with 33–83% decrease in invasion (pLINC03045, identified from effect size and p-value, demonstrated 82.7% decrease in tumor cell invasion upon knockdown, while LINC03045 expression was significantly associated with patient survival and tumor grade(pLINC03045 knockdown revealed that WASF3, previously implicated in tumor invasion studies, was highly correlated with lncRNA expression, while WASF3 KD was associated with significant decrease in invasion. Finally, WASF3 overexpression demonstrated rescue of invasive function lost with LINC03045 KD. Conclusion: CRISPRi screening identified LINC03045, a previously unannotated lncRNA, as critical to GBM invasion. Gene expression is significantly associated with tumor grade and survival. RNA-seq and mechanistic studies suggest that this novel lncRNA may regulate invasion via WASF3.
- 3 June 2023
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 114, 1-8
Carotid artery stenting for asymptomatic stenosis is associated with decreased 30-day readmission at very high volume centers
- 3 June 2023
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 114, 1-8
Carotid artery stenting for asymptomatic stenosis is associated with decreased 30-day readmission at very high volume centers